Tazidime and Umbilical hernia - a phase IV clinical study of FDA data

Summary:

Umbilical hernia is reported as a side effect among people who take Tazidime (ceftazidime), especially for people who are female, 0-1 old, have been taking the drug for < 1 month also take Epivir, and have Constipation.

The phase IV clinical study analyzes which people have Umbilical hernia when taking Tazidime. It is created by eHealthMe based on reports of 10,389 people who have side effects when taking Tazidime from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Umbilical hernia?

Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button) is found to be associated with 644 drugs and 676 conditions by eHealthMe. Check the latest studies of Umbilical hernia.

On Jul, 14, 2026

10,389 people reported to have side effects when taking Tazidime.
Among them, 12 people (0.12%) have Umbilical hernia.

Among these 12 people:

How long have people been on Tazidime when they have Umbilical hernia? *

What is the gender of people who have Umbilical hernia when taking Tazidime? *

female: 75 %
male: 25 %

What is the age of people who have Umbilical hernia when taking Tazidime? *

What are other drugs people take besides Tazidime? *

Epivir: 8 people, 66.67%
Amoxicillin: 6 people, 50.00%
Zidovudine: 6 people, 50.00%
Budesonide: 5 people, 41.67%
Retrovir: 4 people, 33.33%
Folic Acid: 3 people, 25.00%
Omeprazole: 3 people, 25.00%
Ibuprofen: 3 people, 25.00%
Acetaminophen: 3 people, 25.00%
Chlorpheniramine Maleate: 3 people, 25.00%

What are other side effects people have besides Umbilical hernia? *

Premature Baby: 8 people, 66.67%
Alanine Aminotransferase Increased: 8 people, 66.67%
Blood Creatinine Increased: 7 people, 58.33%
Blood Lactic Acid Increased: 7 people, 58.33%
Blood Creatine Phosphokinase Increased: 7 people, 58.33%
Lipase Increased: 7 people, 58.33%
Premature Rupture Of Membranes: 6 people, 50.00%
Aspartate Aminotransferase Increased: 5 people, 41.67%
Blood Lactate Dehydrogenase Increased: 5 people, 41.67%
Anaemia Neonatal: 4 people, 33.33%

What are the existing conditions these people have? *

Wheezing (a high-pitched whistling sound made while you breath): 2 people, 16.67%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 16.67%
Gastric Disorder (disease of stomach): 2 people, 16.67%
Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body): 2 people, 16.67%
Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 16.67%
Lower Respiratory Tract Infection: 2 people, 16.67%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 16.67%
Fungal Nail Infection: 2 people, 16.67%
Constipation: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and have Umbilical hernia?

- Check whether Umbilical hernia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazidime:

Tazidime (10,409 reports)

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Umbilical hernia:

Umbilical hernia (644 drugs)

Browse all the conditions that are associated with Umbilical hernia:

Umbilical hernia (676 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Tazidime) and Tazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.